The Duke Regional Biocontainment Laboratory (RBL) was established with funding from the National Institutes of Health (NIH) to support basic research aimed at developing drugs, diagnostics, and vaccines for emerging and reemerging infections, as well as biodefense. The RBL features a comprehensive safety and operations program, providing state-of-the-art biocontainment facilities for BSL2 and BSL3 research. Since its commissioning in 2007, the RBL has received partial support for construction and renovations from the NIH (UC6-AI058607 and G20-AI167200), and facility support from the NIH (UC7-AI180254).
Contact us to discuss how the RBL can support your research.